Prof. Rafael Kramann is a Founder of Sequantrix^TM. He is a nephrologist dedicated to develop novel targeted therapies for fibrotic diseases. Rafael is Director and Chair of the Department of Renal, Hypertensive, Rheumatological and Immunological Diseases (Department of Medicine II) and Chairman and Founding Director of the Institute of Experimental Medicine and Systems Biology, both at the University Hospital RWTH Aachen, Germany. He is an international opinion leader and inventor in the field of fibrosis and awardee of 2 ERC grants and multiple awards and prizes.